Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Silver North Options GDR Silver Project, Silvertip-Midway District, Yukon (click to learn more) Ciscom Corp. Strengthens Its Board of Directors with Addition of Two Experienced Industry Leaders (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Amarin Corporation plc AMRN

Healthcare Biotechnology
Amarin Corporation PLC is a pharmaceutical company. The Company is focused on the commercialization and development of therapeutics to improve cardiovascular (CV), health and reduce CV risk. The Company operates through the development and commercialization of VASCEPA. Its lead product, Vascepa (icosapent ethyl) capsule is used as an adjunct to diet to reduce triglyceride levels in adult... see more

Recent & Breaking News (NDAQ:AMRN)

Amarin to Present at Rodman & Renshaw’s Global Investment Conference

GlobeNewswire September 6, 2017

Technical Snapshots for These Drug Makers Stocks -- Teva Pharma, Endo, Ionis Pharma, and Amarin

PR Newswire August 23, 2017

Amarin's REDUCE-IT Cardiovascular Outcomes Study of Vascepa to Continue as Planned at Recommendation of Independent Data Monitoring Committee

GlobeNewswire August 14, 2017

Investor Network: Amarin Corporation Plc to Host Earnings Call

Accesswire August 2, 2017

Amarin Reports Second Quarter 2017 Financial Results and Provides Update on Operations

GlobeNewswire August 2, 2017

Investor Calendar Invites You to the Amarin Second Quarter 2017 Earnings Conference Call and Webcast Live on Wednesday, August 2, 2017

Accesswire August 1, 2017

Amarin to Report Second Quarter 2017 Results and Host Conference Call on August 2, 2017

GlobeNewswire July 26, 2017

Technical Reports on Drug Makers Equities -- Teva Pharma, Endo, Ionis Pharma, and Amarin

PR Newswire July 18, 2017

Watch These 7 Huge Call Purchases In Thursday Trade

Benzinga.com  July 13, 2017

Watch These 7 Huge Call Purchases In Thursday Trade

Benzinga.com  July 6, 2017

Watch These 8 Huge Call Purchases In Friday Trade

Benzinga.com  June 30, 2017

15 Biggest Mid-Day Gainers For Tuesday

Benzinga.com  June 27, 2017

Mid-Morning Market Update: Markets Mostly Flat; Accenture Posts In-Line Q3 Earnings

Benzinga.com  June 22, 2017

Technical Snapshots for These Drug Makers Stocks -- Endo, Teva Pharma, Ionis Pharma, and Amarin

PR Newswire June 15, 2017

Amarin Corporation plc (Nasdaq: AMRN) to Ring The Nasdaq Stock Market Opening Bell

GlobeNewswire June 12, 2017

Vascepa® (Icosapent Ethyl) Showed Reductions in Potentially Atherogenic Lipid Parameters in Statin-Treated Women With Type 2 Diabetes and Persistent High Triglycerides

GlobeNewswire June 12, 2017

Amarin to Present at the Jefferies 2017 Global Healthcare Conference

GlobeNewswire June 1, 2017

Amarin Announces Expanded Research Relationships and Studies to Help Improve Cardiovascular Care

GlobeNewswire May 18, 2017

Drug Makers Stocks Under Scanner -- Teva Pharma, Endo, Ionis Pharma, and Amarin

PR Newswire May 4, 2017

Investor Network: Amarin Corporation Plc Sponsored ADR to Host Earnings Call

Accesswire May 3, 2017